These data indicate that TDEVs from GBM cells fuse with the surface of T cells, increase the concentration of adenosine around T cells, activate A2AR and inhibit aerobic glycolysis in T cells, thereby inhibiting the production of energy-carrying substances needed for T-cell clonal proliferation. Here, ADORA2A is linked to glioblastoma.